Antithrombin III is probably not a suitable biomarker for diagnosis of primary central nervous system lymphoma

Antithrombin III (AT III) in cerebrospinal fluid (CSF) has been suggested to have high specificity and sensitivity in separating primary central nervous system (CNS) lymphoma from other neurological conditions. We measured with ELISA CSF and serum AT III and albumin levels in 12 lymphoma patients wi...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Ann Hematol
Auteurs principaux: Kuusisto, Milla Elvi Linnea, Haapasaari, Kirsi-Maria, Remes, Anne Marja, Bloigu, Risto, Karihtala, Peeter, Turpeenniemi-Hujanen, Taina, Kuittinen, Outi
Format: Artigo
Langue:Inglês
Publié: Springer Berlin Heidelberg 2015
Sujets:
Original Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4432105/
https://ncbi.nlm.nih.gov/pubmed/25697593
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00277-015-2334-y
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires